ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2013 41st Annual Meeting | |
| Philip J. Ferrone, MD | Pediatric Retina Surgery — Update and Clinical Pearls |
| Tarek S. Hassan, MD | The Continued Evolution of Vitrectomy: How it Impacts Current Clinical Care |
| Tarek S. Hassan, MD | The Current Management of Refractory Diabetic Macular Edema |
| Daniel F. Martin, MD | Lessons Learned in the Management of Posterior Uveitis |
| Daniel F. Martin, MD | Top 10 Findings from the Comparison of AMD Treatments Trials (CATT) |
| Joan W. Miller, MD | Current and Future Therapies of AMD |
| Joan W. Miller, MD | Neuroprotection for Retinal Disorders |
| Virgilio Morales-Canton, MD | Endophthalmitis from the Retina Surgeon’s Perspective — Complications of Intravitreal Injection Therapy and Pars Plana Vitrectomy |
| Virgilio Morales-Canton, MD | Vitrectomy Management of Complications of Diabetic Retinopathy |
| Timothy G. Murray, MD, MBA | Update on Management for Complex Pediatric Retinoblastoma and Melanoma: Impact of Imaging, Anti-VEGF, and Metabolism on Tumor Control and Functional Outcome |
| David W. Parke, II, MD | What’s the Election’s Healthcare Impact? What Happens Now? |
| John T. Thompson, MD | Advances in the Treatment of Lamellar and Full-Thickness Macular Holes |
| John T. Thompson, MD | Does Vitrectomy Increase the Risk for Development of Glaucoma? |
| Michael T. Trese, MD | Vitreous Relationships to Retinal Disease and Enzymatic Manipulation |
| 2012 40th Annual Meeting | |
| Susanne Binder, MD | Intrasurgical OCT for Membrane Peeling in Patients with Macular Pucker |
| Susanne Binder, MD | Vitreomacular Traction in AMD |
| Neil M. Bressler, MD | Clinically Relevant Impact of CATT on Managing Neovascular AMD |
| Neil M. Bressler, MD | Simplified Treatment Algorithm for DME from DRCR.net |
| R.V. Paul Chan, MD | Treatment Options for Retinopathy of Prematurity |
| Steven T. Charles, MD | 25G Vitrectomy without Scleral Buckling for RRD, PVR, and Giant Breaks |
| Steven T. Charles, MD | Scissors vs. Vitreous Cutters for Diabetic TRD |
| J. Brooks Crawford, MD | Is Ocular Pathology Still Relevant to Clinical Ophthalmology? |
| Donald J. D'Amico, MD | Surgical Management of Severe Macular Edema |
| Pravin U. Dugel, MD | Anti-PDGF Combination Treatment for nvAMD: Beyond Anti-VEGF Monotherapy |
| Pravin U. Dugel, MD | Epimacular Brachytherapy for nvAMD: The CABERNET and MERITAGE Studies |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | NEXT |
